The estimated Net Worth of Capital Co Llc Alafi is at least $295 Million dollars as of 2 October 2017. Capital Alafi owns over 258,065 units of Intra-Cellular Therapies Inc stock worth over $295,388,334 and over the last 10 years Capital sold ITCI stock worth over $0.
Capital has made over 8 trades of the Intra-Cellular Therapies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Capital bought 258,065 units of ITCI stock worth $4,000,008 on 2 October 2017.
The largest trade Capital's ever made was buying 258,065 units of Intra-Cellular Therapies Inc stock on 2 October 2017 worth over $4,000,008. On average, Capital trades about 51,298 units every 132 days since 2014. As of 2 October 2017 Capital still owns at least 3,953,270 units of Intra-Cellular Therapies Inc stock.
You can see the complete history of Capital Alafi stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 8 Admiral Dr #324, Emeryville, CA 94608, USA.
Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus, and Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: